RETRACTED: Cyclin-dependent kinase 7 (CDK7) is an emerging prognostic biomarker and therapeutic target in osteosarcoma

RETRACTED: Cyclin-dependent kinase 7 (CDK7) is an emerging prognostic biomarker and therapeutic target in osteosarcoma

Bibliographic Details
Main Authors:	Hangzhan Ma, Dylan C. Dean, Ran Wei, Francis J. Hornicek, Zhenfeng Duan
Format:	Article
Language:	English
Published:	SAGE Publishing 2021-02-01
Series:	Therapeutic Advances in Musculoskeletal Disease
Online Access:	https://doi.org/10.1177/1759720X21995069

Similar Items

Cyclin-dependent kinase 9 (CDK9) is a novel prognostic marker and therapeutic target in osteosarcomaResearch in context
by: Hangzhan Ma, et al.
Published: (2019-01-01)

RETRACTED: Myc is a prognostic biomarker and potential therapeutic target in osteosarcoma
by: Wenlong Feng, et al.
Published: (2020-05-01)

Expression of Concern: T‐LAK cell‐originated protein kinase (TOPK): an emerging prognostic biomarker and therapeutic target in osteosarcoma
by: Pichaya Thanindratarn, et al.
Published: (2021-12-01)

The role of extracelluar matrix in osteosarcoma progression and metastasis
by: Juncheng Cui, et al.
Published: (2020-09-01)

Androgen receptor is a potential novel prognostic marker and oncogenic target in osteosarcoma with dependence on CDK11
by: Yunfei Liao, et al.
Published: (2017-03-01)

Expression and Clinical Significance of High‐Mobility Group AT‐hook 2 (HMGA2) in Osteosarcoma
by: Juncheng Cui, et al.
Published: (2022-05-01)

Author Correction: Androgen receptor is a potential novel prognostic marker and oncogenic target in osteosarcoma with dependence on CDK11
by: Yunfei Liao, et al.
Published: (2024-01-01)

Cytomegalovirus cyclin-dependent kinase ortholog vCDK/pUL97 undergoes regulatory interaction with human cyclin H and CDK7 to codetermine viral replication efficiency
by: Martin Schütz, et al.
Published: (2023-10-01)

The awakening of the CDK10/Cyclin M protein kinase
by: Gamble, Carly, et al.
Published: (2017)

Regulation of the Pcl7-Pho85 cyclin-cdk complex by Pho81.
by: Lee, M, et al.
Published: (2000)

ATR and p-ATR are emerging prognostic biomarkers and DNA damage response targets in ovarian cancer
by: Wenlong Feng, et al.
Published: (2020-12-01)

Cyclin-dependent kinase (CDK) 4/6 inhibitors in oncology
by: Karamitrousis Evangelos, et al.
Published: (2020-04-01)

CDK7 is a prognostic biomarker for non-small cell lung cancer
by: Christiane Kuempers, et al.
Published: (2022-09-01)

Xenopus phospho-CDK7/cyclin H expressed in baculoviral-infected insect cells.
by: Lawrie, A, et al.
Published: (2001)

Cyclin-dependent kinase 5 (CDK5) regulates the circadian clock
by: Andrea Brenna, et al.
Published: (2019-11-01)

Inhibition of ATR-Chk1 signaling blocks DNA double-strand-break repair and induces cytoplasmic vacuolization in metastatic osteosarcoma
by: Xiaoyang Li, et al.
Published: (2020-09-01)

Cyclin K goes with Cdk12 and Cdk13
by: Kohoutek Jiri, et al.
Published: (2012-04-01)

Molecular cloning of and homology modelling of cyclin dependent kinase 3 (CDK3) /
by: Abdulrahman Nabil M. SH. Shawish, 1992-, author 611420, et al.
Published: (2017)

Molecular cloning of and homology modelling of cyclin dependent kinase 3 (CDK3) /
by: Abdulrahman Nabil M. SH. Shawish, 1992-, 611420
Published: (2017)

Human TFIIH Kinase CDK7 Regulates Transcription-Associated Chromatin Modifications
by: Christopher C. Ebmeier, et al.
Published: (2017-08-01)

mTORC1 Down-Regulates Cyclin-Dependent Kinase 8 (CDK8) and Cyclin C (CycC).
by: Daorong Feng, et al.
Published: (2015-01-01)

Cyclin-dependent kinase 12 (CDK12), human kinase domain; a Target Enabling Package
by: Dixon-Clarke, S
Published: (2018)

Cyclin-Dependent Kinase 12 (CDK12), human kinase domain; A Target Enabling Package
Published: (2018)

Cyclin-Dependent Kinase 12 (CDK12), Human Kinase Domain; A Target Enabling Package
Published: (2018)

Clinicopathological value of the upregulation of cyclin-dependent kinases regulatory subunit 2 in osteosarcoma
by: Chaohua Mo, et al.
Published: (2022-04-01)

Identification and Functional Characterisation of CRK12:CYC9, a Novel Cyclin-Dependent Kinase (CDK)-Cyclin Complex in Trypanosoma brucei.
by: Séverine Monnerat, et al.
Published: (2013-01-01)

Cyclin Dependent Kinase 2 (CDK2) Inhibitors in Oncology Clinical Trials: A Review
by: Isabelle House, et al.
Published: (2025-01-01)

Regulation of neuronal cav3.1 channels by cyclin-dependent kinase 5 (Cdk5).
by: Aida Calderón-Rivera, et al.
Published: (2015-01-01)

Sub-cloning of cyclin-dependent kinase 3 (CDK3) gene into a mammalian expression vector /
by: Alnaseri, Zubaida Talal M., 1996-, author 614711, et al.
Published: (2018)

Sub-cloning of cyclin-dependent kinase 3 (CDK3) gene into a mammalian expression vector /
by: Alnaseri, Zubaida Talal M., 1996-, author 614711
Published: (2018)

Regulation of the G1/S Transition in Hepatocytes: Involvement of the Cyclin-Dependent Kinase Cdk1 in the DNA Replication
by: Anne Corlu, et al.
Published: (2012-01-01)

Cyclin-dependent kinase 9 (CDK9) predicts recurrence in Middle Eastern epithelial ovarian cancer
by: Sandeep Kumar Parvathareddy, et al.
Published: (2021-05-01)

Correction to: The M-phase specific hyperphosphorylation of Staufen2 involved the cyclin-dependent kinase CDK1
by: Rémy Beaujois, et al.
Published: (2018-09-01)

Identification of cyclin-dependent kinase (CDK) 6 as a novel p65 NK-kappaB Ser536 kinase
by: Buss, H, et al.
Published: (2008)

Cyclin B/CDK1 and Cyclin A/CDK2 phosphorylate DENR to promote mitotic protein translation and faithful cell division
by: Katharina Clemm von Hohenberg, et al.
Published: (2022-02-01)

Distinct regions of MAT1 regulate cdk7 kinase and TFIIH transcription activities.
by: Busso, D, et al.
Published: (2000)

A recent tactic for searching CDK-7 kinase inhibitor by NCI database screening
by: Rashid Mohammad, et al.
Published: (2024-01-01)

CRISPR-Cas9-Mediated Silencing of CD44 in Human Highly Metastatic Osteosarcoma Cells
by: Tang Liu, et al.
Published: (2018-04-01)

Cyclin A and Cks1 promote kinase consensus switching to non-proline-directed CDK1 phosphorylation
by: Aymen al-Rawi, et al.
Published: (2023-03-01)

Anticancer screening of medicinal plant phytochemicals against Cyclin-Dependent Kinase-2 (CDK2): An in-silico approach
by: Wajahat Khan, et al.
Published: (2017-08-01)